Peter Barrett, Director at Vitae Pharmaceuticals, Inc (VTAE), bought 74,572 shares at $8.00 ($300K) on 2014-09-29, disclosed to the SEC on 2014-10-01.
Open-market purchase of $300k VTAE by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 37,072 | $0 | 0.0% |
| 2 | $8.00 | 37,500 | $300K | 100.0% |
| Total | $4.02 avg | 74,572 | $300K | 100% |
| Filing → |
| PKI | SELL | 2017-11-14 | $1.0M | — | Filing → |
| PKI | SELL | 2017-06-02 | $632K | — | Filing → |
| HLCS | BUY | 2007-05-31 | $3.0M | — | Filing → |